Thrombotic thrombocytopenic purpura

Area of Science:

• Hematology
• Internal Medicine
• Critical Care Medicine

Background:

• Thrombotic thrombocytopenic purpura (TTP) is a rare, life-threatening disorder characterized by microangiopathic hemolytic anemia, thrombocytopenia, and organ damage.
• Classical TTP presentation includes severely low platelet counts and hemolytic anemia, often accompanied by neurological symptoms.

Observation:

• The patient presented with classical signs of severe TTP, including markedly depressed platelet count and severe hemolytic anemia.
• Neurological symptoms were present but not initially ominous, underscoring the rapid progression potential of untreated TTP.

Findings:

• A combination of treatments, including plasma infusion, plasmapheresis, anti-platelet agents, corticosteroids, and vincristine, was administered.
• The patient showed significant improvement, with plasmapheresis strongly suggested as the primary driver of recovery, despite the use of multiple therapeutic modalities.

Implications:

• This case demonstrates the successful application of modern treatment modalities for TTP, even in remote settings.
• The successful use of plasmapheresis in a community hospital highlights the importance of accessible advanced medical technology and raises questions about its broader implementation and management.
• Further monitoring of plasmapheresis use in community settings is warranted to assess appropriateness and manage potential complications.